During the ICD process, the translocated HMGB1 couples with TLR4 on the surface of DCs to improve the efficient processing and cross-presentation of tumor-associating antigens before apoptosis, thereby activating specific T-cell immune responses (49). Here, HMGB1 is linked to neoplasm.